SecBot SecBot
8-K ·Filed Nov 5, 2026

WEN

Wendy's Co
NEUTRAL
Impact 5/10
Horizonweeks Processed11d 16h ago SEC0001193125-26-448576
8-K material event: Items 1.01
Actionable Insight • Neutral

Monitor whether Trian engages in further negotiations, launches a tender offer at a higher price, or challenges the rights plan in court. The one-year duration of the pill and the absence of dead-hand provisions leave the door open for a negotiated deal if the board deems it fair.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$7.94
T+0 close · Nov 5, 2026 · via day close
Latest settled
+3.02%
T+5 · $8.18
Vs SPY
−0.27%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $7.94entry
  2. T+1 · 11d ago +2.64%α +2.33% · $8.15
  3. T+5 · 5d ago +3.02%α −0.27% · $8.18
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Wendy's adopted a limited-duration shareholder rights plan (poison pill) with a 15% trigger, expiring November 3, 2027, in response to Trian's unsolicited $7.35/share takeover proposal. The independent committee rejected the proposal as undervaluing the company. The board also amended equity plans to remove the Trian/Peltz exclusion from the change-in-control definition and extended post-change-in-control severance protection to 18 months.

Key Facts

  • Board adopted a shareholder rights plan with a 15% beneficial ownership trigger, expiring November 3, 2027
  • Rights plan was adopted in response to Trian-led group's unsolicited $7.35/share cash proposal to acquire shares not already owned by the group
  • Independent committee unanimously rejected the $7.35/share proposal as substantially undervaluing the company
  • Trian is grandfathered as a 15%+ holder but cannot acquire additional shares without triggering the pill
  • Board amended the 2020 Omnibus Award Plan to remove the exclusion for transactions involving Nelson Peltz/Peter W. May from the change-in-control definition
  • Post-change-in-control severance protection period extended from 12 to 18 months under the Executive Severance Pay Policy
  • Rights plan has no dead-hand, slow-hand, or no-hand features
  • Morgan Stanley, Goldman Sachs, and Simpson Thacher are advising the independent committee

Financial Impact

No financial figures disclosed; rights plan has $0.001 per right redemption price; Trian's proposal was $7.35/share cash for shares not already owned

Risk Factors

  • Trian may launch a proxy contest or litigation to challenge the rights plan
  • The rights plan could deter other potential acquirers from making a bid
  • Trian's grandfathered status means it can maintain its current stake without triggering the pill, but any additional purchases would trigger severe dilution

Market Snapshot

Exchange
Nasdaq
Sector
Retail-Eating & Drinking Places
Analyst Consensus
6% bullish (31 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-448576
Document: d305992d8k.htm0001193125-26-448576
Document: d305992dex107.htm0001193125-26-448576
Document: d305992dex106.htm0001193125-26-448576
Document: d305992dex105.htm0001193125-26-448576
Document: d305992dex104.htm0001193125-26-448576
Document: d305992dex31.htm0001193125-26-448576
Document: d305992dex991.htm0001193125-26-448576
Document: d305992dex103.htm0001193125-26-448576
Document: d305992dex102.htm0001193125-26-448576

Track record

11 reports on WEN

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +8.20% at T+5 after the Oct 28, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Neutral 5/10 Viewing Entry $7.94 to $8.15 Now $8.47 +6.68% ▲ +2.64% +2.33% vs SPY
  2. Nov 5, 202611d ago 8-K Bearish 6/10 Entry $7.94 to $8.15 Now $8.47 −6.68% ▼ −2.64% −2.33% vs SPY
  3. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $7.65 to $7.94 Now $8.47 +10.72% ▲ +3.79% +8.20% vs SPY
  4. Oct 28, 202619d ago SC 13D/A Bullish 6/10 Entry $7.07 to $7.17 Now $8.47 +19.80% ▲ +1.34% +1.73% vs SPY
  5. Aug 17, 202613w ago 8-K Neutral 3/10 Entry $8.44 to $8.93 Now $8.47 +0.36% ▲ +5.81% +5.60% vs SPY
  6. Aug 7, 202614w ago 8-K Bearish 8/10 Entry $7.69 to $7.28 Now $8.47 −10.17% ▲ +5.33% +5.30% vs SPY
  7. Jul 9, 202618w ago Press Release Neutral 1/10 Entry $7.55 Now $8.47 +12.19% No price data
  8. Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $6.79 to $6.79 Now $8.47 −24.74% · 0.00% +0.54% vs SPY
  9. Jun 9, 202622w ago 8-K Neutral 2/10 Entry $6.63 to $6.79 Now $8.47 +27.75% ▲ +2.41% +0.71% vs SPY
  10. May 22, 202625w ago 8-K Neutral 3/10 Entry $7.36 to $7.48 Now $8.47 +15.11% ▲ +1.64% +1.63% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Wed (9h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026